Vascular depression: Myth or reality?

International Psychogeriatrics

Volumn 20, Issue 4, 2008, Pages 645-652

  Almeida, Osvaldo P ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

AGING; ANHEDONIA; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONCEPTUAL FRAMEWORK; DEPRESSION; DISEASE COURSE; DISEASE PREDISPOSITION; EDITORIAL; FRONTAL LOBE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LABORATORY DIAGNOSIS; MEDLINE; PATHOGENESIS; PREVALENCE; PSYCHOMOTOR RETARDATION; RISK FACTOR; VASCULAR DEPRESSION; VASCULAR DISEASE;

AGED; CAUSALITY; CEREBROVASCULAR DISORDERS; DEPRESSIVE DISORDER; HUMANS; MYTHOLOGY; RESEARCH;

EID: 43949136148     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610207006473     Document Type: Editorial

References (35)

1. Alexopoulos, G. S., Meyers, B. S., Young, R. C., Campbell, S., Silbersweig, D. and Charlson, M. (1997). "Vascular depression" hypothesis. Archives of General Psychiatry, 54, 915-922.
2. Almeida, O. P., Burton, E. J., Ferrier, N., McKeith, I. G. and O'Brien, J. T. (2003). Depression with late onset is associated with right frontal lobe atrophy. Psychological Medicine, 33, 675-681.
3. Almeida, O. P. et al. (2004). Association between homocysteine, depression and cognitive function in community-dwelling women from Australia. Journal of the American Geriatrics Society, 52, 327-328.
4. Almeida, O. P., Waterreus, A. and Hankey, G. J. (2006). Preventing depression after stroke: results from a randomized, placebo-controlled trial. Journal of Clinical Psychiatry, 67, 1104-1109.
5. Almeida, O. P. et al. (2007). Association of cardiovascular risk factors and disease with depression in later life. American Journal of Geriatric Psychiatry, 15, 506-513.
6. Australian Bureau of Statistics (ABS) (1998). Mental Health and Well Being: Profile of Adults, Australia. ABS Catalogue no. 4326.0. Canberra: ABS.
7. Australian Institute of Health and Welfare (AIWH) (2004). Heart, Stroke and Vascular Diseases: Australian Facts 2004. AIHW Catalogue no. CVD 27 (Cardiovascular Disease Series No. 22). Canberra: AIHW and National Heart Foundation of Australia.
8. Beats, B. C., Sahakian, B. J. and Levy, R. (1996). Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychological Medicine, 26, 591-603.
9. Bonaa, K. H. et al. for the NORVIT Trial Investigators (2006). Homocysteine lowering and cardiovascular events after acute myocardial infarction. New England Journal of Medicine, 354, 1578-1588.
10. Carson, A. J. et al. (2000). Depression after stroke and lesion location: a systematic review. Lancet, 356, 122-126.
11. de Leeuw, F. E. et al. (2001). Prevalence of cerebral white matter lesions in elderly people: a population-based magnetic resonance imaging study. The Rotterdam Scan Study. Journal of Neurology, Neurosurgery and Psychiatry, 70, 9-14.
12. Dickens, C., McGowan, L., Clark-Carter, D. and Creed, F. (2002). Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosomatic Medicine, 64, 52-60.
13. Fletcher, A. E. et al. (2002). Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial. Journal of Hypertension, 20, 2069-2079.
14. Flicker, L. et al. (2006). Efficacy of B-vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia. Stroke, 37, 547-549.
15. Ford, A. H., Flicker, L., Thomas, J., Norman, P., Jamrozik, K. and Almeida, O. P. (unpublished at the time of submission). Depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial of vitamins B12, B6 and folic acid.
16. Hackett, M. L., Yapa, C., Parag, V. and Anderson, C. S. (2005). Frequency of depression after stroke: a systematic review of observational studies. Stroke, 36, 1330-1340.
17. Hentschel, E. et al. (1993). Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. New England Journal of Medicine, 328, 308-312.
18. Kessler, R. C. et al. (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289, 3095-3105.
19. Krishnan, K. R. et al. (2002). Comorbidity of depression with other medical diseases in the elderly. Biological Psychiatry, 15, 559-588.
20. Marshall, B. J. (2005). Helicobacter connections. Nobel lecture, 8 December 2005. (http://nobelprize.org/nobel_prizes/medicine/laureates/2005/ marshall-lecture.pdf).
21. Marshall, B. J. and Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1, 1311-1315.
22. Marshall, B. J. et al. (1988). Prospective double-blind trial of duodenal ulcer relapse after eradication of campylobacter pylori. Lancet, 2, 1437-1442.
23. Naarding, P. et al. (2007). Clinically defined vascular depression in the general population. Psychological Medicine, 37, 383-392.
24. Norwood, R. (2006). Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Current Opinion in Pulmonary Medicine, 12, 113-117.
25. O'Brien, J., Ames, D., Chiu, E., Schweitzer, I., Desmond, P. and Tress, B. (1998). Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ, 317, 982-984.
26. Rainer, M. K. et al. (2006). Data from the VITA Study do not support the concept of vascular depression. American Journal of Geriatric Psychiatry, 14, 531-537.
27. Ried, L. D., Tueth, M. J., Handberg, E., Kupfer, S. and Pepine, C. J. for the INVEST Study Group. (2005). Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension treatment strategy in the International Verapamil SR-Trandolapril Study (INVEST). Psychosomatic Medicine, 67, 398-406.
28. Scull, A. (1987). Desperate remedies: a Gothic tale of madness and modern medicine. Psychological Medicine, 17, 561-577.
29. Scull, A. (2005). Desperate remedies. Princeton Alumni Weekly, 105 (14), 24-29.
30. Stewart, R. A., Sharples, K. J., North, F. M., Menkes, D. B., Baker, J. and Simes, J. (2000). Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators. Archives of Internal Medicine, 160, 3144-3152.
31. Taylor, M. J., Carney, S., Geddes, J. and Goodwin, G. (2003). Folate for depressive disorders. Cochrane Database of Systematic Reviews, 2, CD003390.
32. Tiemeier, H., van Tuijl, H. R., Hofman, A., Meijer, J., Kiliaan, A. J. and Breteler, M. M. (2002). Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. American Journal of Psychiatry, 159, 2099-2101.
33. Thomas, A. J. et al. (2002). Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Archives of General Psychiatry, 59, 785-792.
34. Thombs, B. D. et al. (2006). Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine, 21, 30-38.
35. Wald, D. S., Law, M. and Morris, J. K. (2002). Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 325, 1202.